|Published||Report Code||Available Format||Pages|
The global clinical nutrition market was valued at $39,339.4 million in 2015, and it is expected to grow at a CAGR of 5.4% during 2016–2022. The increase in the elderly population and fertility rate, surge in the cases of malnutrition patients and premature births, and growing incidence of cancer and central nervous system-related diseases are driving the growth of the c market.
The surging geriatric population is leading to the growth of the clinical nutrition market. As people grow older, the digestive system becomes inefficient, and therefore extracting essential nutrients from food becomes difficult. Among the aged, appetite loss is a common issue, and it leads to nutrient deficiency. In order to meet the required nutrition intake, clinical nutrition products are recommended for the aging population.
GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT $M (2012–2022)
Asia-Pacific (APAC) held the largest share in the clinical nutrition market in 2015, and the region is further projected to witness significant growth during the forecast period. The increasing birth rate, along with the growing geriatric population and high number of people with malnutrition, is driving the growth of the market in the region.
Based on product, the clinical nutrition market has been categorized into enteral nutrition, infant nutrition, and parenteral nutrition. Infant nutrition is further categorized into soy-based, milk-based, probiotic/prebiotic, organic, and others. Enteral nutrition is categorized into standard and enteral nutrition for chronic illness. The various parenteral nutrition types include amino acids, dextrose, fats, and additives.
Among the three primary categories within the product segment, infant nutrition generated the highest revenue in the clinical nutrition market in 2015. Breastfeeding infants during the first six months plays a vital role in their growth and development. During the initial stages of human life, any nutrient deficiency can lead to retardation in mental development and physical growth and a high risk of anemia, infections, and blindness.
Infant nutrition plays a critical role in the development of prematurely born children and its importance has increased manifold with growing awareness, in turn, driving the clinical nutrition market. Further, high-birth-rate nations commonly witness more cases of premature births. Generally, long-term health issues are observed in people who had a premature birth. Sensory deficit, cerebral palsy, learning disabilities, and respiratory illnesses are common conditions found among prematurely born children, who are more vulnerable to them. In cases where mothers are unable to or choose to not breastfeed their infants, various infant formulas are offered by market players as suitable alternatives. Such infant products are available via varied retail channels, such as supermarkets and convenience stores.
Enteral nutrition provides nourishment which is transferred directly into the human body in form of fluids. Further, tube feeding is a common type of enteral nutrition. Tube feeding is generally offered to individuals, who cannot meet their daily nutritional needs, and to those who are vulnerable to uncontrollable vomiting or suffering from constipation.
Parenteral nutrition is offered to patients primarily for daily nutritional requirements, which cannot be met via the normal digestive pathway, due to their inability to naturally extract the required nutrients from food. Parenteral nutrition is a process of intravenous feeding, wherein nutrients are delivered as a solution through a special catheter and tubing.
Some of the major players operating in the global clinical nutrition market are Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Nestlé S.A., Perrigo Company PLC, Danone S.A., Mead Johnson & Company LLC, and Fresenius Kabi AG.
Key questions answered in the report